GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial

ConditionsAcute Lymphoblastic Leukemia Leukemia Non-Hodgkin's Lymphoma

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorGoethe University

About this trial

The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.

Eligibility criteria

Qualifiers

Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols

Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols

Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols

Age minimum 18 yrs

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

10,000 Participants

are grouped into 2 trial groups

Locations152

Select a site below to view it on the map.

Austria

Germany

Sponsors and collaborators

Goethe University

Lead sponsor

Source ClinicalTrials.gov